Sweden· SE-20100116000025
Teysuno 20 mg/5,8 mg/15,8 mg Kapsel, hård
A medicinal product containing tegafur + gimeracil + oteracil, registered in Sweden by Nordic Group BV.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Tegafur + Gimeracil + Oteracil
- Manufacturer
- Nordic Group BV
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20100116000025
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tegafur + gimeracil + oteracil in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTEYSUNONordic Group BV, Hoofddorp
- SpainTEYSUNO 15 mg/4,35 mg/11,8 mg CAPSULAS DURASNordic Group B.V.
- FinlandTeysunoNordic Group BV
- United KingdomTeysuno 15mg/4.35mg/11.8mg capsulesNordic Pharma Ltd
- IrelandTeysuno 15 mg/4.35 mg/11.8 mg hard capsulesNordic Group B.V.
- IcelandTeysunoNordic Group BV
- NetherlandsTeysuno 15 mg/4,35 mg/11,8 mg harde capsulesNordic Group BV
- NorwayTeysunoNordic Group BV
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Teysuno
- Iceland · Teysuno
- Liechtenstein · Teysuno
- Norway · Teysuno
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d08d3144-1745-4c7c-9cb1-88fd2fb2900b GET /v1/drugs/d08d3144-1745-4c7c-9cb1-88fd2fb2900b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20100116000025",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20100116000025",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/teysuno-epar-product-information_sv.pdf"
}See everything about tegafur + gimeracil + oteracil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.